N-Acetylcysteine normalizes brain oxidative stress and neuroinflammation observed after protracted ethanol abstinence: a preclinical study in long-term ethanol-experienced male rats


Por: S. FERNANDEZ-RODRIGUEZ, M. CANO-CEBRIAN, C. ESPOSITO-ZAPERO, S. PEREZ, C. GUERRI, T. ZORNOZA and A. POLACHE

Publicada: 1 abr 2023 Ahead of Print: 1 ene 2023
Resumen:
RationaleUsing a preclinical model based on the Alcohol Deprivation Effect (ADE), we have reported that N-Acetylcysteine (NAC) can prevent the relapse-like drinking behaviour in long-term ethanol-experienced male rats.ObjectivesTo investigate if chronic ethanol intake and protracted abstinence affect several glutamate transporters and whether NAC, administered during the withdrawal period, could restore the ethanol-induced brain potential dysfunctions. Furthermore, the antioxidant and anti-inflammatory effects of NAC during abstinence in rats under the ADE paradigm were also explored.MethodsThe expression of GLT1, GLAST and xCT in nucleus accumbens (Nacc) and dorsal striatum (DS) of male Wistar was analysed after water and chronic ethanol intake. We used the model based on the ADE within another cohort of male Wistar rats. During the fourth abstinence period, rats were treated for 9 days with vehicle or NAC (60, 100 mg/kg; s.c.). The effects of NAC treatment on (i) glutamate transporters expression in the Nacc and DS, (ii) the oxidative status in the hippocampus (Hip) and amygdala (AMG) and (iii) some neuroinflammatory markers in prefrontal cortex (PFC) were tested.ResultsNAC chronic administration during protracted abstinence restored oxidative stress markers (GSSG and GGSH/GSH) in the Hip. Furthermore, NAC was able to normalize some neuroinflammation markers in PFC without normalizing the observed downregulation of GLT1 and GLAST in Nacc.ConclusionsNAC restores brain oxidative stress and neuroinflammation that we previously observed after protracted ethanol abstinence in long-term ethanol-experienced male rats. This NAC effect could be a plausible mechanism for its anti-relapse effect. Also, brain oxidative stress and neuroinflammation could represent and identify plausible targets for searching new anti-relapse pharmacotherapies.

Filiaciones:
:
 Univ Valencia, Fac Pharm, Dept Pharm & Pharmaceut Technol & Parasitol, Burjassot 46100, Valencia, Spain

M. CANO-CEBRIAN:
 Univ Valencia, Fac Pharm, Dept Pharm & Pharmaceut Technol & Parasitol, Burjassot 46100, Valencia, Spain

C. ESPOSITO-ZAPERO:
 Univ Valencia, Fac Pharm, Dept Pharm & Pharmaceut Technol & Parasitol, Burjassot 46100, Valencia, Spain

S. PEREZ:
 Univ Valencia, Fac Pharm, Dept Physiol, Burjassot 46100, Valencia, Spain

:
 Principe Felipe Res Ctr, Dept Mol & Cellular Pathol Alcohol, Valencia, Spain

T. ZORNOZA:
 Univ Valencia, Fac Pharm, Dept Pharm & Pharmaceut Technol & Parasitol, Burjassot 46100, Valencia, Spain

A. POLACHE:
 Univ Valencia, Fac Pharm, Dept Pharm & Pharmaceut Technol & Parasitol, Burjassot 46100, Valencia, Spain
ISSN: 00333158





PSYCHOPHARMACOLOGY
Editorial
SPRINGER, ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES, Alemania
Tipo de documento: Article
Volumen: 240 Número: 4
Páginas: 725-738
WOS Id: 000918733500001
ID de PubMed: 36708386
imagen hybrid, Green Published

MÉTRICAS